FIRST WAVE BIOPHARMA (FWBI) Stock Analyst Ratings
NASDAQ:FWBI - Nasdaq - US33749P4081 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to FWBI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 36.72. This target is 1140.54% above the current price.
FWBI was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about FWBI.
In the previous month the buy percentage consensus was at a similar level.
FWBI was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-25 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-03-15 | Roth MKM | Maintains | Buy -> Buy |
| 2024-01-03 | Roth MKM | Maintains | Buy -> Buy |
| 2023-09-19 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-07-14 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-06-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-26 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-05 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-31 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-26 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-12-02 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-26 | Roth Capital | Maintains | Buy |
| 2021-12-07 | Maxim Group | Downgrade | Buy -> Hold |